These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16432876)

  • 1. Polymorphic transformation of indomethacin under high pressures.
    Okumura T; Ishida M; Takayama K; Otsuka M
    J Pharm Sci; 2006 Mar; 95(3):689-700. PubMed ID: 16432876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin: new polymorphs of an old drug.
    Surwase SA; Boetker JP; Saville D; Boyd BJ; Gordon KC; Peltonen L; Strachan CJ
    Mol Pharm; 2013 Dec; 10(12):4472-80. PubMed ID: 24025118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow coloration phenomena of incorporated indomethacin into folded sheet mesoporous materials.
    Tanabe S; Higashi K; Umino M; Limwikrant W; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jun; 429(1-2):38-45. PubMed ID: 22446085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
    Otsuka M; Kato F; Matsuda Y; Ozaki Y
    AAPS PharmSciTech; 2003; 4(2):E19. PubMed ID: 12916901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel standard sample powder preparation method for quantitative analysis of polymorphs.
    Okumura T; Otsuka M
    J Pharm Sci; 2005 May; 94(5):1013-23. PubMed ID: 15793799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
    Lee HE; Lee MJ; Kim WS; Jeong MY; Cho YS; Choi GJ
    Int J Pharm; 2011 Nov; 420(2):274-81. PubMed ID: 21907779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
    Hédoux A; Paccou L; Guinet Y; Willart JF; Descamps M
    Eur J Pharm Sci; 2009 Sep; 38(2):156-64. PubMed ID: 19591926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide).
    Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T
    Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H; Iwata M; Ito M; Noguchi S
    Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control.
    Xu T; Nahar K; Dave R; Bates S; Morris K
    Pharm Res; 2018 May; 35(7):140. PubMed ID: 29748722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triboelectrification and dissolution property enhancements of solid dispersions.
    Asare-Addo K; Šupuk E; Al-Hamidi H; Owusu-Ware S; Nokhodchi A; Conway BR
    Int J Pharm; 2015 May; 485(1-2):306-16. PubMed ID: 25772415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and solid-state characteristics of a new crystal form of indomethacin.
    Lin SY
    J Pharm Sci; 1992 Jun; 81(6):572-6. PubMed ID: 1522497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.